Metformin Use and Survival Outcomes in Endometrial Cancer: A Systematic Review and Meta-Analysis

Oncotarget - United States
doi 10.18632/oncotarget.20388
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Metformin Use Improves Survival of Diabetic Liver Cancer Patients: Systematic Review and Meta-Analysis

Oncotarget
Oncology
2016English

Effect of Metformin Use on the Risk and Prognosis of Endometrial Cancer: A Systematic Review and Meta-Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Obesity and Endometrial Cancer Survival: A Systematic Review

International Journal of Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2012English

Survival Benefits of Metformin for Colorectal Cancer Patients With Diabetes: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Impact of Metformin on Clinical Outcomes Among Men With Prostate Cancer: A Systematic Review and Meta-Analysis

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2015English

Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2016English

Cancer Antigen-125 and Outcomes in Acute Heart Failure: A Systematic Review and Meta-Analysis

Heart Asia
Cardiovascular MedicineCardiology
2018English

Risk of Pre-Eclampsia in Women Taking Metformin: A Systematic Review and Meta-Analysis

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

CD147 and Prostate Cancer: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy